| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Alix T Coste | |
| Artan Graf | |||
| Farid Chaabane | |||
| Léonard Jequier | |||
| P2860 | cites work | Mechanisms of action of 5-fluorocytosine | Q28366384 |
| The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans | Q28469346 | ||
| Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species | Q28829671 | ||
| Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents | Q33689421 | ||
| Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis | Q33701491 | ||
| Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates | Q33938068 | ||
| Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene | Q34045325 | ||
| Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris | Q34492906 | ||
| First hospital outbreak of the globally emerging Candida auris in a European hospital | Q34543358 | ||
| Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses | Q34547546 | ||
| Resistance of Candida albicans biofilms to antifungal agents in vitro | Q35118735 | ||
| Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters | Q35120105 | ||
| Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia | Q35131728 | ||
| Antifungal drug resistance mechanisms. | Q37463223 | ||
| Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation | Q37607324 | ||
| Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel | Q37664411 | ||
| Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Healthcare Surface | Q38659451 | ||
| Effectiveness of Disinfectants Against Candida auris and Other Candida Species | Q39092133 | ||
| Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species | Q39092300 | ||
| Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation | Q39092330 | ||
| Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris. | Q39092336 | ||
| Antifungal resistance and new strategies to control fungal infections | Q39751373 | ||
| Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment. | Q40040802 | ||
| Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions. | Q41931964 | ||
| Differential activities of three families of specific beta(1,3)glucan synthase inhibitors in wild-type and resistant strains of fission yeast | Q42584992 | ||
| Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast | Q44588054 | ||
| Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen | Q48220845 | ||
| Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. | Q49823075 | ||
| Importation, Mitigation, and Genomic Epidemiology of Candida auris at a Large Teaching Hospital. | Q50061342 | ||
| Surface disinfection challenges for Candida auris: an in-vitro study. | Q50083499 | ||
| A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. | Q50083987 | ||
| First report of sporadic cases of Candida auris in Colombia | Q50110515 | ||
| Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris. | Q51782762 | ||
| Candida auris Infection Leading to Nosocomial Transmission, Israel, 2017. | Q51783505 | ||
| Candida auris in contemporary mycology labs: A few practical tricks to identify it reliably according to one recent French experience. | Q52345840 | ||
| Understanding echinocandin resistance in the emerging pathogen Candida auris. | Q52597955 | ||
| Candida auris: Disinfectants and Implications for Infection Control. | Q53690366 | ||
| An outbreak due to Candida auris with prolonged colonization and candidemia in a tertiary care European hospital. | Q53695503 | ||
| The first isolate of Candida auris in China: clinical and biological aspects. | Q55312173 | ||
| Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance. | Q55689919 | ||
| A Candida auris Outbreak and Its Control in an Intensive Care Setting | Q57029894 | ||
| outbreak was linked to reusable axillary temperature probes, study finds | Q57052896 | ||
| Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey | Q57187360 | ||
| Limited Mutations Identified in Isolates of Candida auris Directly Contribute to Reduced Azole Susceptibility | Q58701183 | ||
| Candida auris in Healthcare Facilities, New York, USA, 2013-2017 | Q58794314 | ||
| Candida auris: An emerging drug resistant yeast – A mini-review | Q59286513 | ||
| Conserved Role for Biofilm Matrix Polysaccharides in Drug Resistance | Q60922206 | ||
| Clinical spectrum and factors impacting outcome of Candida auris: a single center study from Pakistan | Q64064934 | ||
| Management of Patients with Candida auris Fungemia at Community Hospital, Brooklyn, New York, USA, 2016-2018 | Q64076153 | ||
| Direct Detection of Emergent Fungal Pathogen Candida auris in Clinical Skin Swabs by SYBR Green-Based Quantitative PCR Assay | Q64136308 | ||
| Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance | Q64137661 | ||
| Fluorescence studies on the molecular action of amphotericin B on susceptible and resistant fungal cells | Q71165727 | ||
| First report of Candida auris infections from Saudi Arabia | Q89080493 | ||
| Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris | Q91339456 | ||
| Killing of Candida auris by UV-C: Importance of exposure time and distance | Q91480249 | ||
| Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs | Q91603053 | ||
| Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities | Q91612680 | ||
| Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data | Q91624375 | ||
| On the Origins of a Species: What Might Explain the Rise of Candida auris? | Q91715567 | ||
| Emergence of Candida auris in Russia | Q92240878 | ||
| A Rapid and Automated Sample-to-Result Candida auris Real-Time PCR Assay for High-Throughput Testing of Surveillance Samples with the BD Max Open System | Q92481814 | ||
| Analysis of Candida auris fungemia at a single facility in Kenya | Q92658740 | ||
| Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting | Q92662301 | ||
| Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients | Q92680432 | ||
| Candida auris outbreak on a vascular ward - the unexpected arrival of an anticipated pathogen | Q92906250 | ||
| Candida auris outbreak report from Pakistan: a success story of infection control in ICUs of a tertiary care hospital | Q92986492 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Candida auris | Q26816853 |
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 2788 | |
| P577 | publication date | 2019-11-29 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris | |
| P478 | volume | 10 |
Search more.